deficiency aatd homozygosity protease inhibitor pi z variant predisposes childhood liver disease pulmonary emphysema NUMBER neonates aatd develop liver disease NUMBER overall progress severe disease aatd principal genetic indication liver transplantation children liver pathology associated accumulation abnormally folded protein hepatocytes principal producers circulating aat currently unknown small proportion pi zz individuals progress clinically significant cirrhosis aat gene shows significant variation hypothesized cryptic genetic variants aat gene contribute susceptibility liver disease study consisting NUMBER patients established liver disease NUMBER homozygous pi zz patients presented chronic obstructive pulmonary disease n NUMBER NUMBER index cases NUMBER unaffected sibs asymptomatic n NUMBER evidence liver disease identified single nucleotide polymorphism snp conferred significant risk liver disease p NUMBER frequency snp different NUMBER pi zz cases chronic obstructive pulmonary disease compared NUMBER nonindex cases snp appears confer susceptibility liver disease reporter gene assays failed functional differences alleles conclusion description genetic modifier liver disease homozygous zz children potential implications screening possible therapies currently developed alpha1 antitrypsin alpha1 antitrypsin case control moderate severe